Home/Recalls/CANADA-75607
Health CanadaType I

Jamp Digoxin tablet: Over-sized tablet

Published: June 3, 2024Recall ID: 75607Category: generalCountry: Canada

Reason for Recall / Hazard

Product quality

Product Description & Identification

Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Affected Products

Jamp Digoxin tablet

Additional Source Details

FieldValue
N I D75607
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/jamp-digoxin-tablet-over-sized-tablet
IssueProduct quality
TitleJamp Digoxin tablet: Over-sized tablet
ProductJamp Digoxin tablet
Archived0
CategoryDrugs
Last updated2024-06-03
OrganizationDrugs and health products
Recall classType I
What you should doReturn your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType I
Official Agency Alert